1. A Monoclonal Antibody that Binds Anionic Phospholipids on Tumor Blood Vessels Enhances the Antitumor Effect of Docetaxel on Human Breast Tumors in Mice
   Xianming Huang et al, 2005, Cancer Research CrossRef
2. Synthesis of Bromoundecyl Resorc[4]arenes and Applications of the Cone Stereoisomer as Selector for Liquid Chromatography
   Silvia Corradi et al, 2018, The Journal of Organic Chemistry CrossRef
3. Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging
   Susan M. Galbraith et al, 2003, Journal of Clinical Oncology CrossRef
4. Metabolic Imaging by Hyperpolarized 13C Magnetic Resonance Imaging for In vivo Tumor Diagnosis
   Klaes Golman et al, 2006, Cancer Research CrossRef
5. Effect of Vascular Targeting Agent in Rat Tumor Model: Dynamic Contrast-enhanced versus Diffusion-weighted MR Imaging
   Harriet C. Thoeny et al, 2005, Radiology CrossRef
6. Diffusion-weighted MR Imaging in Monitoring the Effect of a Vascular Targeting Agent on Rhabdomyosarcoma in Rats
   Harriet C. Thoeny et al, 2005, Radiology CrossRef
7. Intravoxel Incoherent Motion Diffusion-weighted MRI Assessing the Effect of the Vascular Disrupting Agent CA4P on VX2 Liver Tumors in Rabbits
   Ting Qian et al, 2023, Current Medical Imaging Formerly Current Medical Imaging Reviews CrossRef
8. Tumour vascular disrupting agents: combating treatment resistance
   G M Tozer et al, 2008, The British Journal of Radiology CrossRef
9. Measuring tumour vascular response to antivascular and antiangiogenic drugs
   G M Tozer, 2003, The British Journal of Radiology CrossRef
10. Nitric Oxide Synthase Inhibition Enhances the Tumor Vascular-Damaging Effects of Combretastatin A-4 3-O-Phosphate at Clinically Relevant Doses
    Gillian M. Tozer et al, 2009, Clinical Cancer Research CrossRef